The TRUST Study - CardioVascular Imaging IMT

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.

Also called NCT02832934

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 184 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02832934
Other papers using this trial's data
  • Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial The Journal of clinical endocrinology and metabolism, 2018-08-01 DOI, PubMed 29846630

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02832934. Randomized; quadruple masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The TRUST Study - CardioVascular Imaging IMT
Condition
Thyroid Dysfunction
Condition
Atherosclerosis
Condition
Heart Failure
Intervention (Drug)
Levothyroxine
Intervention (Drug)
Placebo
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)
Collaborator
University of Lausanne Hospitals (class: other)
Collaborator
University Hospital, Geneva (class: other)

Record details

Record id
cardio:ct-nct02832934
Content hash
b53388caa13ed46d1ea598169aaa59b285058f7023cb9d8d711be72925a3266e